期刊
JOURNAL OF CONTROLLED RELEASE
卷 335, 期 -, 页码 38-48出版社
ELSEVIER
DOI: 10.1016/j.jconrel.2021.05.008
关键词
Drug delivery; Micelle; Neutrophil; Rheumatoid arthritis; LMWH; TOS
资金
- National Natural Science Foundation [81690261, 81974499]
- Sichuan Province Science and Technology Support Program [2018RZ0136]
A novel anti-inflammatory strategy based on neutrophils has been developed, showing significant therapeutic efficacy for rheumatoid arthritis by using LMWH-TOS nanoparticles.
Rheumatoid arthritis (RA) is characterized by the outbreak of inflammation. Neutrophils, the main culprit of the outbreak of inflammation, are the first inflammatory cells to be recruited to inflamed joints and facilitate the recruitment of themselves by stimulating the release of chemokines. Here, based on neutrophils, a novel antiinflammatory shield and sword soldiers strategy is established with LMWH-TOS nanoparticles (LT NPs). The hydrophilic fragment low molecular weight heparin (LMWH) acts as a shield which block the transvascular movement of neutrophils through inhibiting the adhesion cascade by binding to P-selectin on inflamed endothelium. Synergistically, MMP-9, which is secreted by the recruited neutrophils and degrade the main component of articular cartilage, is reduced by the hydrophobic fragment d-alpha-tocopheryl succinate (TOS), functioning as a sword. In collagen-induced arthritis (CIA) mouse model, LT NPs show significant targeting effect, and exhibit prominent therapeutic efficacy after enveloping the first-line anti-RA drug methotrexate. Our work proves that the multi-stage manipulation of neutrophils is feasible and effective, providing a new concept for RA treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据